Literature DB >> 27501707

Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats.

Shuhua Mu1, Youlan Li2, Bingbing Liu3, Weiping Wang2, Si Chen2, Jiajia Wu2, Lisi OuYang2, Yaxi Zhu2, Keyi Li2, Mali Zhan2, Zongwei Liu2, Yu Jia2, Yuxin Ma2, Wanlong Lei4.   

Abstract

Oxidative stress is closely involved in neurodegenerative diseases. The present study aimed to examine the effect of anti-oxidant DHM (dihydromyricetin) on 3NP (3-nitropropionic acid) -induced behavioral deficits of experimental rats and striatal histopathological injury by using behavioral, imaging, biochemistry, histochemistry and molecular biology technologies. The experimental results showed that both motor dysfunctions and learning and memory impairments induced by 3NP were significantly reduced after DHM treatment. 3NP-induced striatal metabolic abnormality was also remarkably improved by DHM treatment, showed as the increased glucose metabolism in PET/CT scan, decreased MDA (malondialdehyde) and increased SOD (superoxide dismutase) activity in enzyme histochemical staining. In addition, the cell apoptosis was evidently detected in the striatum of the 3NP group, while in the 3NP + DHM group, the number of apoptotic cells was remarkably reduced. 3NP treatment obviously induced down-regulation of Bcl-2, and up-regulations of Bax and Cleaved Caspase-3, while these changes were significantly reversed by DHM treatment. The present results suggested that DHM showed its protective effect by anti-oxidant and anti-apoptosis mechanisms.

Entities:  

Keywords:  3NP; Apoptosis; DHM; Oxidative stress; Striatum

Mesh:

Substances:

Year:  2016        PMID: 27501707     DOI: 10.1007/s12031-016-0801-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  44 in total

1.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Authors:  S J Tabrizi; M W Cleeter; J Xuereb; J W Taanman; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

3.  Melatonin reduces projection neuronal injury induced by 3-nitropropionic acid in the rat striatum.

Authors:  Shuhua Mu; Erjian Lin; Bingbing Liu; Yuxin Ma; Lisi OuYang; Youlan Li; Si Chen; Jian Zhang; Wanlong Lei
Journal:  Neurodegener Dis       Date:  2014-10-22       Impact factor: 2.977

4.  The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.

Authors:  Yuxin Ma; Mali Zhan; Lisi OuYang; Youlan Li; Si Chen; Jiajia Wu; Jiachang Chen; Cheng Luo; Wanlong Lei
Journal:  Behav Brain Res       Date:  2014-03-05       Impact factor: 3.332

5.  Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.

Authors:  Asha Srinivasan; Chellappagounder Thangavel; Yi Liu; Sunday Shoyele; Robert B Den; Ponniah Selvakumar; Ashakumary Lakshmikuttyamma
Journal:  Mol Carcinog       Date:  2015-05-12       Impact factor: 4.784

6.  Protective effect of melatonin on 3-NP induced striatal interneuron injury in rats.

Authors:  Shuhua Mu; Lisi OuYang; Bingbing Liu; Yaxi Zhu; Keyi Li; Mali Zhan; Zongwei Liu; Yu Jia; Wanlong Lei
Journal:  Neurochem Int       Date:  2011-06-12       Impact factor: 3.921

7.  Heat shock transcription factor-1 suppresses apoptotic cell death and ROS generation in 3-nitropropionic acid-stimulated striatal cells.

Authors:  Yong-Joon Choi; Ji-Yeon Om; Nam-Ho Kim; Ji-Eun Chang; Jun Ho Park; Ji-Young Kim; Hee Jae Lee; Sung-Soo Kim; Wanjoo Chun
Journal:  Mol Cell Biochem       Date:  2012-12-06       Impact factor: 3.396

8.  Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.

Authors:  Puneet Kumar; Anil Kumar
Journal:  J Med Food       Date:  2009-06       Impact factor: 2.786

9.  The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.

Authors:  Z Sun; J Xie; A Reiner
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

10.  Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.

Authors:  Q Huang; D Zhou; E Sapp; H Aizawa; P Ge; E D Bird; J P Vonsattel; M DiFiglia
Journal:  Neuroscience       Date:  1995-03       Impact factor: 3.590

View more
  5 in total

Review 1.  The Versatile Effects of Dihydromyricetin in Health.

Authors:  Hongliang Li; Qisheng Li; Zhaowen Liu; Kai Yang; Zhixi Chen; Qilai Cheng; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-30       Impact factor: 2.629

Review 2.  Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin.

Authors:  Jingyao Zhang; Yun Chen; Huiqin Luo; Linlin Sun; Mengting Xu; Jin Yu; Qigang Zhou; Guoliang Meng; Shengju Yang
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

Review 3.  PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.

Authors:  Hui-Zhi Long; Yan Cheng; Zi-Wei Zhou; Hong-Yu Luo; Dan-Dan Wen; Li-Chen Gao
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

4.  Dihydromyricetin promotes longevity and activates the transcription factors FOXO and AOP in Drosophila.

Authors:  Xiaolan Fan; Yao Zeng; Ziqiang Fan; Liang Cui; Wenhao Song; Qi Wu; Yue Gao; Deying Yang; Xueping Mao; Bo Zeng; Mingwang Zhang; Qingyong Ni; Yan Li; Tao Wang; Diyan Li; Mingyao Yang
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

Review 5.  Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases.

Authors:  Hilda Martínez-Coria; Martha X Mendoza-Rojas; Isabel Arrieta-Cruz; Héctor E López-Valdés
Journal:  Front Pharmacol       Date:  2019-11-11       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.